The markets opened higher with the Dow rising 26 points to 17,789 as crude oil prices rebounded.  Nasdaq added 8 points to 4,894.

On the upside

China granted regulatory clearance to Cytori Therapeutics’ (Nasdaq: CYTX) exclusive licensee Lorem Vascular to market and sell the Cytori Celution System.

Bristol-Myers (NYSE: BMY) entered an exclusive strategic collaboration with uniQure (Nasdaq: QURE) to develop gene therapies for cardiovascular diseases.

Shares of Voltari (Nasdaq: VLTC) continued climbing.

On the downside

Regulatory approval of the merger between Hudson City Bancorp (Nasdaq: HCBK) and M&T Bank has been delayed.

Wunderlich analyst Irene Haas downgraded Magnum Hunter Resources (NYSE: MHR) from a Buy rating to a Hold rating.
 
Profit taking weighed down shares of Nymox Pharmaceutical (Nasdaq: NYMX).

In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 3 on the NYSE while decliners barely edged out advancers by a slim margin on Nasdaq. The broader S&P 500 rose 3 points to 2070. Bitcoin added $1 to $257.